MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 475108-18-0
Formula C22H19ClN4O5MW 454.9Research-use catalog entryCOA/SDS by request

Tivozanib

CAS Number: 475108-18-0

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
1 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
50 mg
Purity
98+%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
98 mg
Purity
86.1%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: SPMVMDHWKHCIDT-UHFFFAOYSA-NC22H19ClN4O5 | MW 454.9

Chemical Absolute Identifiers

CAS Number

475108-18-0

PubChem CID

9911830

Molecular Formula

C22H19ClN4O5

Molecular Weight

454.9 g/mol

Exact Mass

454.104397

InChIKey

SPMVMDHWKHCIDT-UHFFFAOYSA-N

IUPAC Name

1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea

SMILES String

COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC

Physical Properties

Water Solubility

1 mol/L

pKa

11.74

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Tivozanib (CAS 475108-18-0) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C22H19ClN4O5 and molecular weight 454. 90 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Mitogen-activated protein kinase 3 (Homo sapiens) — 4 assays; Vascular endothelial growth factor receptor 2 (Homo sapiens) — 10 assays; Mitogen-activated protein kinase 1 (Homo sapiens) — 4 assays; Vascular endothelial growth factor receptor 1 (Homo sapiens) — 5 assays; Vascular endothelial growth factor receptor 3 (Homo sapiens) — 6 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Mitogen-activated protein kinase 3

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents · best pChEMBL 9.89

Experimental evidence source: ChEMBL

Vascular endothelial growth factor receptor 2

Homo sapiens · SINGLE PROTEIN · 10 qualifying assays · 8 documents · best pChEMBL 9.8

Experimental evidence source: ChEMBL

Mitogen-activated protein kinase 1

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents · best pChEMBL 9.74

Experimental evidence source: ChEMBL

Vascular endothelial growth factor receptor 1

Homo sapiens · SINGLE PROTEIN · 5 qualifying assays · 4 documents · best pChEMBL 9.68

Experimental evidence source: ChEMBL

Vascular endothelial growth factor receptor 3

Homo sapiens · SINGLE PROTEIN · 6 qualifying assays · 4 documents · best pChEMBL 9.62

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Tivozanib

Names & Synonyms

AV951AV951 cpd1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)ureaUrea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-tivozanibum
Show all synonyms
1-(2-chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methyl-1,2-oxazol-3-yl)ureaUREA, N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)-Tivozanib (AV-951)1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)ureaAV 951C22H19ClN4O5N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREAKRN 9511-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREAN-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)ureaTivozanib [USAN]AV-951(Tivozanib)Tivozanib [USAN:INN]
External Identifiers
EC NUMBER: 968-821-5DSSTOX SUBSTANCE ID: DTXSID20963865CHEMBL ID: CHEMBL1289494CHEBI ID: CHEBI:91327UNII: 172030934TDRUGBANK ID: DB11800HMDB ID: HMDB0304847KEGG ID: D09683METABOLOMICS WORKBENCH ID: 152897NCI THESAURUS CODE: C85444RXCUI: 2534233WIKIDATA ID: Q7810457Kil-8951
Literature & Patent References
DOI 10.1016/j.bmc.2023.117561Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.DOI 10.1016/j.ejmech.2024.116561An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents.PMID 38157838Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.PMID 38870832An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents.DOI 10.1016/j.ejmech.2023.115626Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies.DOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.6019/EOS300108ECBD screening data for assay EOS300108PMID 37453330Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-chloroanilineCAS 286371-44-6
4-Chloro-6,7-dimethoxyquinolineCAS 35654-56-9
6,7-Dimethoxy-4-hydroxyquinolineCAS 127285-54-5
3,4-Dimethoxyphenyl methyl ketoneCAS 1131-62-0

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 120685-11-2MidostaurinCAS 146535-11-76,7-Dimethoxy-3-phenylquinoxalineCAS 189232-42-6BohemineCAS 286371-44-64-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-chloroanilineCAS 35654-56-94-Chloro-6,7-dimethoxyquinolineCAS 1072-67-93-Amino-5-methylisoxazoleCAS 530-62-11,1'-CarbonyldiimidazoleCAS 443913-73-3VandetanibCAS 319460-85-0AxitinibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamate

RFQ questions for CAS 475108-18-0

What are the key identifiers for Tivozanib (CAS 475108-18-0)?

Tivozanib is identified by CAS 475108-18-0, with molecular formula C22H19ClN4O5, molecular weight 454.9, InChIKey SPMVMDHWKHCIDT-UHFFFAOYSA-N.

Does CAS 475108-18-0 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Mitogen-activated protein kinase 3, Vascular endothelial growth factor receptor 2, Mitogen-activated protein kinase 1, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor receptor 3. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 475108-18-0?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Tivozanib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 475108-18-0 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.